Our writer, Jeff Miller, is also a columnist on Real Money – and through this we have access to the insightful commentary of his colleagues. Detailed below will be several observations by other Real Money writers as of November 5.

James Altucher was the first to note that Asian markets were experiencing positive numbers “on the heels of an Obama win.” He also dug up a couple of Obama’s very own stock picks: AVII, a company developing cures for “diseases related to bioterror,” and Skyterra, a satellite company. According to Altucher, stem cell stocks are also likely to be sensitive, most notably STEM.

Altucher later appeared on CNBC to discuss his favorite Obama sectors: Infrastructre (KBR and MTW), Healthcare (HMA), and Taxes (TYW); and overall he stressed stocks that were cheap and worthy of buying “regardless of policy.”

Jim Gulbrandsen warned that trying to play off any Obama boom in infrastructure could be problematic if the company doesn’t have significant US sales.

Gulbransen also suggested the possibility that Obama could turn out to be like Lula, President of Brazil, who has encouraged Brazil’s greatest capitalist prosperity.

Ken Wolff figured the market wasn’t reacting the election in any predictible fashion, considering oil numbers were on their way up.

Tim Melvin expressed an interesting point of view in response to those who feel Obama’s presidency will be just like Carter’s. Melvin had strong convictions in claiming that there will be market opportunities no matter who is in the White House, citing the vast swaths of money made by Buffet under Carter’s administration.

None other than Jim Cramer recommended GM and F because Obama would not let those stocks fail. Jeff Dorman agreed and added that “their fates are tied to government intervention.”